[roughly]

Well, even getting past the human/medical side - one thing the computer/VC people miss coming into the field is Bio is both expensive and not amenable to the kinds of growth/pricing curves computers have been. It costs money to grow a cell strain in a tube, but to grow 100 cell strains, it costs… 100x as much. It takes 24 minutes for E.coli to reproduce, but in another couple years we’ll be able to get that down to… 24 minutes. There’s opportunities for improving the cost, reducing the spend on reagents (or finding better ones), reducing the number of strains required, that kind of thing, but the computer/internet/digital industry’s basically priced a Moore’s law curve in on everything, and that just doesn’t work in Bio. The capital costs are large and the time to iterate is really slow compared to digital.